Literature DB >> 21899256

Hexose transporter GLUT1 harbors several distinct regulatory binding sites for flavones and tyrphostins.

Alejandra Pérez1, Paola Ojeda, Lorena Ojeda, Mónica Salas, Coralia I Rivas, Juan C Vera, Alejandro M Reyes.   

Abstract

The facilitative hexose transporter GLUT1 activity is blocked by tyrosine kinase inhibitors that include natural products such as flavones and isoflavones and synthetic compounds such as tyrphostins, molecules that are structurally unrelated to the transported substrates [Vera, et al. (2001) Biochemistry, 40, 777-790]. Here we analyzed the interaction of GLUT1 with quercetin (a flavone), genistein (an isoflavone), and tyrphostin A47 and B46 to evaluate if they share one common or have several binding sites on the protein. Kinetic assays showed that genistein, quercetin, and tyrphostin B46 behave as competitive inhibitors of equilibrium exchange and zero-trans uptake transport and noncompetitive inhibitors of net sugar exit out of human red cells, suggesting that they interact with the external surface of the GLUT1 molecule. In contrast, tyrphostin A47 was a competitive inhibitor of equilibrium exchange and zero-trans exit transport and a noncompetitive inhibitor of net sugar entry into red cells, suggesting that it interacts with the cytoplasmic surface of the transporter. Genistein protected GLUT1 against iodide-elicited fluorescence quenching and also decreased the affinity of d-glucose for its external binding site, while quercetin and tyrphostins B46 and A47 promoted fluorescence quenching and did not affect the external d-glucose binding site. These findings are explained by a carrier that presents at least three binding sites for tyrosine kinase inhibitors, in which (i) genistein interacts with the transporter in a conformation that binds glucose on the external surface (outward-facing conformation), in a site which overlaps with the external binding site for d-glucose, (ii) quercetin and tyrphostin B46 interact with the GLUT1 conformation which binds glucose by the internal side of the membrane (inward-facing conformation), but to a site accessible from the external surface of the protein, and (iii) the binding site for tyrphostin A47 is accessible from the inner surface of GLUT1 by binding to the inward-facing conformation of the transporter. These data provide groundwork for a molecular understanding of how the tyrosine kinase inhibitors directly affect glucose transport in animal cells.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21899256     DOI: 10.1021/bi200748b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1.

Authors:  Kathryn E Hamilton; Janelle F Rekman; Leesha K Gunnink; Brianna M Busscher; Jordan L Scott; Andrew M Tidball; Nathan R Stehouwer; Grace N Johnecheck; Brendan D Looyenga; Larry L Louters
Journal:  Biochimie       Date:  2018-05-29       Impact factor: 4.079

2.  Anticancer agents interacting with membrane glucose transporters.

Authors:  C Granchi; S Fortunato; F Minutolo
Journal:  Medchemcomm       Date:  2016-07-08       Impact factor: 3.597

3.  Macrophage embedded fibrin gels: an in vitro platform for assessing inflammation effects on implantable glucose sensors.

Authors:  Matthew T Novak; Fan Yuan; William M Reichert
Journal:  Biomaterials       Date:  2014-08-28       Impact factor: 12.479

4.  Red wine and green tea flavonoids are cis-allosteric activators and competitive inhibitors of glucose transporter 1 (GLUT1)-mediated sugar uptake.

Authors:  Ogooluwa A Ojelabi; Kenneth P Lloyd; Julie K De Zutter; Anthony Carruthers
Journal:  J Biol Chem       Date:  2018-10-25       Impact factor: 5.157

Review 5.  Natural compounds regulate glycolysis in hypoxic tumor microenvironment.

Authors:  Jian-Li Gao; Ying-Ge Chen
Journal:  Biomed Res Int       Date:  2015-01-22       Impact factor: 3.411

6.  The Impact of Soy Isoflavones on MCF-7 and MDA-MB-231 Breast Cancer Cells Using a Global Metabolomic Approach.

Authors:  Alina Uifălean; Stefanie Schneider; Philipp Gierok; Corina Ionescu; Cristina Adela Iuga; Michael Lalk
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

7.  Effect of nordihydroguaiaretic acid on cell viability and glucose transport in human leukemic cell lines.

Authors:  David Leon; Daniela Parada; Mauricio Vargas-Uribe; Alejandra A Perez; Lorena Ojeda; Angara Zambrano; Alejandro M Reyes; Mónica Salas
Journal:  FEBS Open Bio       Date:  2016-08-23       Impact factor: 2.693

8.  Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro.

Authors:  Alberto Camacho; Juan Carlos Segoviano-Ramírez; Adriana Sánchez-Garcia; Jose de Jesus Herrera-de la Rosa; Jaime García-Juarez; Carlos Alberto Hernandez-Puente; Geovana Calvo-Anguiano; Sergio Rodolfo Maltos-Uro; Alejandra Olguin; Gabriel Gojon-Romanillos; Gabriel Gojon-Zorrilla; Rocio Ortiz-Lopez
Journal:  Lipids Health Dis       Date:  2018-05-29       Impact factor: 3.876

9.  Natural compounds as regulators of the cancer cell metabolism.

Authors:  Claudia Cerella; Flavia Radogna; Mario Dicato; Marc Diederich
Journal:  Int J Cell Biol       Date:  2013-05-16

10.  Facilitated uptake of a bioactive metabolite of maritime pine bark extract (pycnogenol) into human erythrocytes.

Authors:  Max Kurlbaum; Melanie Mülek; Petra Högger
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.